Stock Screener App

Frei -

Installieren

7.29

8.00% 0.54

Precision Biosciences Inc (DTIL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Precision Biosciences Inc Aktie (DTIL) Neueste Nachrichten

Precision BioSciences, Inc. Actuals & Estimates (DUS:PBS0) - TradingView

Price to sales forward of Precision BioSciences, Inc. – NASDAQ:DTIL - TradingView

Precision BioSciences Inc (DTIL) Valuation: PE, PB & Fair Value Analysis - TradingKey

Price to earnings forward of Precision BioSciences, Inc. – NASDAQ:DTIL - TradingView

Precision BioSciences, Inc. Actuals & Estimates (NASDAQ:DTIL) - TradingView

Enterprise value to EBIT forward of Precision BioSciences, Inc. – LS:A400AS - TradingView

DTIL Forecast — Price Target — Prediction for 2027 - TradingView

Precision BioSciences earnings calendar and gene-editing focus, shares remain a small-cap biotech pl - Ad-hoc-news.de

Precision BioSciences Inc (DTIL) Institutional Confidence - TradingKey

Precision BioSciences Inc (DTIL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Precision BioSciences (DTIL) AGM 2026 Summary - Quartr

Precision BioSciences Inc (DTIL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Precision BioSciences Inc (DTIL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Precision BioSciences Inc (DTIL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Precision BioSciences Inc (DTIL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Precision BioSciences Inc (DTIL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Precision BioSciences Inc (DTIL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Precision BioSciences Extends Term Loan Maturity to 2029 - TipRanks

Precision BioSciences Extends Term Loan Maturity to 2029 in Amendment With Banc of California - TradingView

Precision BiosciencesEnters First Amendment To Loan And Security Agreement With Banc Of CaliforniaSEC Filing - TradingView

Precision BioSciences (NASDAQ: DTIL) amends loan and extends term to 2029 - Stock Titan

Precision BioSciences, Inc. Amends Loan and Security Agreement with Banc of California - marketscreener.com

Oppenheimer Maintains Precision BioSciences(DTIL.US) With Buy Rating, Raises Target Price to $20 - Moomoo

DTIL Initiated Coverage by Oppenheimer -- Rating Set to Outperfo - GuruFocus

These stocks are gapping in today's session - ChartMill

Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlitetm in Landmark CREDENCE Trial - Lelezard

[Form 4] PRECISION BIOSCIENCES INC Insider Trading Activity - Stock Titan

Director at Precision Bio (NASDAQ: DTIL) receives 20,979 restricted stock units - Stock Titan

Precision Biosciences (DTIL) director receives grant of 20,979 restricted stock units - Stock Titan

Precision BioSciences (DTIL) director receives grant of 20,979 RSUs - Stock Titan

Precision BioSciences stock (US74019P1084): shares edge higher amid biotech volatility - AD HOC NEWS

H.C. Wainwright Reaffirms Their Buy Rating on Precision BioSciences (DTIL) - The Globe and Mail

Executive at Precision BioSciences (DTIL) receives 57,389 RSU compensation award - Stock Titan

Precision BioSciences (DTIL) awards 107,604 RSUs to General Counsel - Stock Titan

Precision BioSciences (NASDAQ: DTIL) CEO receives 573,888 restricted stock units - Stock Titan

Precision BioSciences (DTIL) Jefferies Global Healthcare 2026 Conference Summary - Quartr

Precision BioSciences (DTIL) Jefferies Global Healthcare Conference 2026 Summary - Quartr

Tyra Biosciences Expands Precision Oncology Clinical Pipeline - asatunews.co.id

Analysts Conflicted on These Healthcare Names: MannKind (MNKD), Biohaven Ltd. (BHVN) and Precision BioSciences (DTIL) - The Globe and Mail

DTIL Stock Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL) - ChartMill

Guggenheim Maintains Precision BioSciences(DTIL.US) With Buy Rating, Maintains Target Price $19 - Moomoo

Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026 - New Castle News

Precision BioSciences Shareholders Approve Incentive Plan and Directors - The Globe and Mail

DTIL Reiterates by HC Wainwright & Co. -- Price Target Maintained at $60 - GuruFocus

Precision BioSciences (DTIL) Unveils Groundbreaking Data on PBGE - GuruFocus

Precision BioSciences Put Its ARCUS Gene Editing Data Front And Center - Finimize

Precision BioSciences, Inc. (DTIL) Discusses Updates on PBG and HBV Program and ELIMINATE-B Trial ResultsSlideshow (NASDAQ:DTIL) 2026-05-27 - Seeking Alpha

Precision BioSciences stock jumps on hepatitis B trial data By Investing.com - Investing.com South Africa

Precision BioSciences stock jumps on hepatitis B trial data - Investing.com

Precision BioSciences Reports Promising New Hepatitis B Trial Data - TipRanks

Why Is Precision BioSciences Stock Gaining Wednesday?Precision BioSciences (NASDAQ:DTIL) - Benzinga

Precision BioSciences Approves Amendments to 2019 Incentive Award Plan and Certificate of Incorporation - minichart.com.sg

New PBGENE-HBV hepatitis B data from Precision BioSciences (Nasdaq: DTIL) - Stock Titan

Experimental gene edit targets hepatitis B DNA in early patient biopsies - Stock Titan

BNTX

$91.22

1.36%

ROIV

$34.07

0.15%

RPRX

$56.23

2.82%

MRNA

$67.27

12.59%

ONC

$279.89

1.65%

RVMD

$182.08

2.19%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters